EMERGENT BIOSOLUTIONS INC's ticker is EBS and the CUSIP is 29089Q105. A total of 205 filers reported holding EMERGENT BIOSOLUTIONS INC in Q3 2016. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $69,000 | -88.3% | 1,091 | -82.9% | 0.00% | -90.9% |
| Q1 2021 | $591,000 | +0.2% | 6,364 | -3.3% | 0.02% | -8.3% |
| Q4 2020 | $590,000 | +441.3% | 6,584 | +524.1% | 0.02% | +380.0% |
| Q3 2020 | $109,000 | +505.6% | 1,055 | +245.9% | 0.01% | +400.0% |
| Q1 2020 | $18,000 | +200.0% | 305 | +190.5% | 0.00% | – |
| Q4 2019 | $6,000 | +20.0% | 105 | 0.0% | 0.00% | – |
| Q3 2019 | $5,000 | 0.0% | 105 | 0.0% | 0.00% | – |
| Q2 2019 | $5,000 | -44.4% | 105 | -26.6% | 0.00% | -100.0% |
| Q4 2018 | $9,000 | +800.0% | 143 | +652.6% | 0.00% | – |
| Q3 2018 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
| Q2 2018 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | -50.0% | 19 | -62.0% | 0.00% | – |
| Q3 2016 | $2,000 | -33.3% | 50 | -50.0% | 0.00% | -100.0% |
| Q2 2016 | $3,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zebra Capital Management LLC | 20,591 | $895,000 | 1.43% |
| Global Alpha Capital Management Ltd. | 330,270 | $14,357,000 | 1.39% |
| AIMZ Investment Advisors, LLC | 73,875 | $3,211,000 | 1.25% |
| Hillcrest Asset Management LLC | 184,010 | $7,999,000 | 1.22% |
| Bridge City Capital, LLC | 56,869 | $2,472,000 | 1.02% |
| SNYDER CAPITAL MANAGEMENT L P | 683,700 | $29,720,000 | 0.72% |
| EARNEST PARTNERS LLC | 2,188,606 | $95,139,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 343,347 | $14,925,000 | 0.53% |
| PALISADE CAPITAL MANAGEMENT, LP | 584,957 | $25,428,000 | 0.52% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 45,693 | $1,986,000 | 0.45% |